| Human insulin |
| Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN) <JP/US> |
| Insulin human, isophane (USP) |
| Insulin human zinc (USP) |
| Insulin human zinc, extended (USP) |
| Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN) <JP> |
| Insulin zinc, prompt (USP) |
| Insulin zinc (USP) |
| Proinsulin human (USAN) |
| Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18) <JP> |
| Insulin analog, fast-acting |
| Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN) <JP/US> |
| Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN) <JP/US> |
| Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN) <JP/US> |
| Insulin analog, long-acting |
| Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN) <JP/US> |
| Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN) <JP/US> |
| Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN) <JP/US> |
| Insulin peglispro (USAN/INN) |
| Insulin icodec (USAN/INN); Insulin icodec (genetical recombination) (JAN) |
| Insulin (JAN/USP) |
| Insulin degludec (genetical recombination) and insulin aspart (genetical recombination) <JP> |
| Combination of insulin analog and GLP-1 receptor agonist |
| Insulin glargine and lixisenatide <JP/US> |
| Insulin degludec and liraglutide <JP/US> |
